Monday, June 15, 2026

NVIDIA Stock Prices to Soar from $788 to $1,200

NVIDIA, which announced its earnings on the...

Novo Nordisk’s Oral Wegovy Just Put Up a Number That Could Change the Obesity Drug Race

Novo Nordisk's oral obesity treatment, Wegovy, saw $400M in Q1 2026 sales, exceeding estimates and indicating strong market demand.

From Poké Ball to Push Start: Hyundai Turns Cars Into a Pokémon Experience

Hyundai Motor Company introduces Pokémon-themed display options for vehicles, enhancing personalization and driving experience.

Tag: CKDB-501A

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us